Juxtafoveal Choroidal Neovascularization Secondary to Persistent Placoid Maculopathy Treated with Intravitreal Bevacizumab

Abstract

Purpose: To describe a case of persistent placoid maculopathy (PPM) associated with juxtafoveal choroidal neovascularization (CNV) treated with intravitreal bevacizumab injection (IVBI).

Design: Interventional case report.

Methods: A 60-year-old patient referred for sudden vision loss was diagnosed with PPM complicated by a disciform scar in the right eye and juxtafoveal CNV in the left eye, undergoing 2 IVBIs.

Results: Best-corrected visual acuity passed from 20/32 to 20/20 after 2 IVBIs, with complete resolution of intraretinal and subretinal fluid and disappearance of fluorescein leakage.

Conclusions: IVBI is a promising treatment option for juxtafoveal CNV secondary to PPM.

KEYWORDS::

• choroidal neovascularization
• intravitreal bevacizumab injection
• persistent placoid maculopathy

Declaration of interest: The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.

Note: Figures 1 & 2 in this article are available in colour online at www.informahealthcare.com/oii